Search

Your search keyword '"Nakashima, Taku"' showing total 398 results

Search Constraints

Start Over You searched for: Author "Nakashima, Taku" Remove constraint Author: "Nakashima, Taku"
398 results on '"Nakashima, Taku"'

Search Results

51. First‐line osimertinib treatment in a patient with lung adenocarcinoma with coexisting epidermal growth factor receptorG719S and de novo T790M mutations

52. Primary Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma with the High Expression of IgG4: A Case Report

53. Dupilumab as an adjunct treatment for a patient with steroid-dependent immunoglobulin G4-related disease complicated by asthma: a case report

54. Dupilumab as an adjunct treatment for a patient with steroid-dependent immunoglobulin G4-related disease complicated by asthma: a case report.

56. Pneumatosis Intestinalis following Radiation Esophagitis during Chemoradiotherapy for Lung Cancer: A Case Report

57. Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive‐stage small cell lung cancer: Two case reports

58. Accelerated decline in lung function in adults with a history of remitted childhood asthma

60. MO10-2 Association of pre-existing interstitial lung abnormalities with immune checkpoint inhibitor-induced interstitial lung disease among patients with non-lung cancers

61. IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis

62. Prognostic Significance of EGFR Gene Mutation in Patients With EGFR Mutated Non-small Cell Lung Cancer Who Received Best Supportive Care Alone

63. Additional file 3 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis

64. Additional file 5 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity

65. Additional file 9 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis

66. Additional file 7 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity

67. Additional file 1 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis

68. Additional file 4 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis

69. Additional file 2 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis

71. Additional file 6 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity

72. Additional file 4 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity

73. Additional file 8 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity

74. Additional file 3 of Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity

75. Additional file 8 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis

76. Additional file 6 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis

78. Additional file 1 of Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis

79. Additional file 7 of Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis

80. Vocal cord dysfunction detected by a three-dimensional image of dynamic change in respiratory resistance in a patient with difficult-to-treat asthma: a case report.

82. Vocal cord dysfunction detected by a three-dimensional image of dynamic change in respiratory resistance in a patient with difficult-to-treat asthma: a case report

83. Risk factors associated with increased discontinuation rate of trimethoprim–sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study

84. Analysis of microRNA Expression in Liquid-Based Cytology Samples May Be Useful for Primary Lung Cancer Diagnosis

85. Autoantibody Positivity Is a Risk Factor for Chemotherapy-induced Exacerbation of Interstitial Pneumonia in Lung Cancer

86. D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis

87. A machine-learning based approach to quantify fine crackles in the diagnosis of interstitial pneumonia

88. Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma

92. Additional file 1 of Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis

93. Two Cases of Cranial Nerve Metastasis Treated with Radiotherapy and Chemotherapy in Patients with Lung Adenocarcinoma

94. Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor–Induced Interstitial Lung Disease Among Patients With Nonlung Cancers

95. Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer

96. Concomitant emphysema might increase the false-negative rate of urinary antigen tests in patients with pneumococcal pneumonia: results from a retrospective study

100. Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis

Catalog

Books, media, physical & digital resources